ATLN
ATLANTIC INTERNATIONAL CORP.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.90
+0.00%Latest reported
- Last report date
- Jun 22, 2026
- EPS actual
- -$0.44
- EPS estimate
- -$0.18
- Revenue actual
- $249.9M
- Revenue estimate
- $111.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -27.5%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 22, 2026 | -$0.18 | -$0.44 | Miss -144.44% | $249.9M |
| Nov 14, 2025 | -$0.18 | -$0.20 | Miss -11.11% | $110.1M |
| Aug 13, 2025 | — | -$0.20 | — | $102.9M |
| Mar 28, 2025 | — | -$1.64 | — | $129.5M |
| Nov 13, 2024 | — | -$0.16 | — | $107.8M |
| Aug 14, 2024 | — | -$0.72 | — | $104.6M |
| Mar 30, 2024 | — | -$2.87 | — | — |
| Dec 30, 2023 | -$3.60 | -$3.26 | Beat 9.41% | — |
| Sep 29, 2023 | -$5.20 | -$3.33 | Beat 35.96% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jun 22, 2026